Skip to content
Awesome – Lifestyle
Author:
Refined Energy Corp.
Refined Energy Acquires Option to Purchase the Golden Goose Project, Newfoundland
July 6, 2026
Diakonos Oncology Reports Positive Clinical Data from Phase 1 Pancreatic Cancer Study and Expanded Access Program in Glioblastoma at AACR and AAN 2026
May 12, 2026
Diakonos Oncology Awarded Fast Track Designation by FDA for DOC1021 (dubodencel) in Unresectable or Metastatic Cutaneous Melanoma
May 7, 2026
Refined Energy Completes Maiden Drill Program at Dufferin West, Intersects Unconformity
April 2, 2026
/C O R R E C T I O N — Diakonos Oncology/
April 1, 2026
Diakonos Oncology to Showcase DOC1021 (dubodencel) Clinical Data in Pancreatic Cancer and Glioblastoma at AACR and ANN 2026
March 18, 2026
Refined Energy Successfully Intersects Targeted Unconformity in Maiden Drill Hole at Dufferin West; Advances Drilling on High-Priority EM Conductor
March 17, 2026
Dufferin West Drilling Commences Maiden Drill Program at High-Priority Dufferin West Uranium Target
March 5, 2026
Refined Energy Corp. Announces Further Extension to Marketing Program
March 5, 2026